367 related articles for article (PubMed ID: 21777178)
1. Molecular targeted approaches for treatment of pancreatic cancer.
Huang ZQ; Saluja AK; Dudeja V; Vickers SM; Buchsbaum DJ
Curr Pharm Des; 2011; 17(21):2221-38. PubMed ID: 21777178
[TBL] [Abstract][Full Text] [Related]
2. Pancreatic cancer: optimizing treatment options, new, and emerging targeted therapies.
Chiorean EG; Coveler AL
Drug Des Devel Ther; 2015; 9():3529-45. PubMed ID: 26185420
[TBL] [Abstract][Full Text] [Related]
3. Pancreatic cancer subtypes: a roadmap for precision medicine.
Torres C; Grippo PJ
Ann Med; 2018 Jun; 50(4):277-287. PubMed ID: 29537309
[TBL] [Abstract][Full Text] [Related]
4. Signal Transducer and Activator of Transcription 3, Mediated Remodeling of the Tumor Microenvironment Results in Enhanced Tumor Drug Delivery in a Mouse Model of Pancreatic Cancer.
Nagathihalli NS; Castellanos JA; Shi C; Beesetty Y; Reyzer ML; Caprioli R; Chen X; Walsh AJ; Skala MC; Moses HL; Merchant NB
Gastroenterology; 2015 Dec; 149(7):1932-1943.e9. PubMed ID: 26255562
[TBL] [Abstract][Full Text] [Related]
5. Perspectives in the treatment of pancreatic adenocarcinoma.
Cid-Arregui A; Juarez V
World J Gastroenterol; 2015 Aug; 21(31):9297-316. PubMed ID: 26309356
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic trends in pancreatic ductal adenocarcinoma (PDAC).
Chandana S; Babiker HM; Mahadevan D
Expert Opin Investig Drugs; 2019 Feb; 28(2):161-177. PubMed ID: 30539678
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic resistance of pancreatic cancer: Roadmap to its reversal.
Yu S; Zhang C; Xie KP
Biochim Biophys Acta Rev Cancer; 2021 Jan; 1875(1):188461. PubMed ID: 33157162
[TBL] [Abstract][Full Text] [Related]
8. New developments in pancreatic cancer treatment.
Krug S; Michl P
Minerva Gastroenterol Dietol; 2012 Dec; 58(4):427-43. PubMed ID: 23207616
[TBL] [Abstract][Full Text] [Related]
9. Novel Therapeutics for Pancreatic Adenocarcinoma.
Lowery MA; O'Reilly EM
Hematol Oncol Clin North Am; 2015 Aug; 29(4):777-87. PubMed ID: 26226910
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and pharmacodynamics of new drugs for pancreatic cancer.
Sugarman R; Patel R; Sharma S; Plenker D; Tuveson D; Saif MW
Expert Opin Drug Metab Toxicol; 2019 Jul; 15(7):541-552. PubMed ID: 31241371
[No Abstract] [Full Text] [Related]
11. Promising new therapies in advanced pancreatic adenocarcinomas.
Kundranda M; Kachaamy T
Future Oncol; 2014 Dec; 10(16):2629-41. PubMed ID: 25531049
[TBL] [Abstract][Full Text] [Related]
12. ATP-binding cassette transporters in progression and clinical outcome of pancreatic cancer: What is the way forward?
Adamska A; Falasca M
World J Gastroenterol; 2018 Aug; 24(29):3222-3238. PubMed ID: 30090003
[TBL] [Abstract][Full Text] [Related]
13. Inhibiting tumor necrosis factor-alpha diminishes desmoplasia and inflammation to overcome chemoresistance in pancreatic ductal adenocarcinoma.
Zhao X; Fan W; Xu Z; Chen H; He Y; Yang G; Yang G; Hu H; Tang S; Wang P; Zhang Z; Xu P; Yu M
Oncotarget; 2016 Dec; 7(49):81110-81122. PubMed ID: 27835602
[TBL] [Abstract][Full Text] [Related]
14. New therapeutic targets in pancreatic cancer.
Lai E; Puzzoni M; Ziranu P; Pretta A; Impera V; Mariani S; Liscia N; Soro P; Musio F; Persano M; Donisi C; Tolu S; Balconi F; Pireddu A; Demurtas L; Pusceddu V; Camera S; Sclafani F; Scartozzi M
Cancer Treat Rev; 2019 Dec; 81():101926. PubMed ID: 31739115
[TBL] [Abstract][Full Text] [Related]
15. Newer Trends in Pancreatic Cancer Treatment: Genetic Alterations and the Role of Immune Therapeutic and Targeted Therapies.
Hussain I; Rashid MU; Sarvepalli D; Rahman AU; Ullah W; Badar H; Jehanzeb S; Khan AK; Khan MT; Muzammil M; Ahmad S
Crit Rev Oncog; 2019; 24(2):157-177. PubMed ID: 31679211
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of drug resistance of pancreatic ductal adenocarcinoma at different levels.
Du J; Gu J; Li J
Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32677676
[TBL] [Abstract][Full Text] [Related]
17. Targeting hypoxic tumor microenvironment in pancreatic cancer.
Tao J; Yang G; Zhou W; Qiu J; Chen G; Luo W; Zhao F; You L; Zheng L; Zhang T; Zhao Y
J Hematol Oncol; 2021 Jan; 14(1):14. PubMed ID: 33436044
[TBL] [Abstract][Full Text] [Related]
18. Recent advances in chemotherapy for pancreatic cancer: evidence from Japan and recommendations in guidelines.
Okusaka T; Furuse J
J Gastroenterol; 2020 Apr; 55(4):369-382. PubMed ID: 31997007
[TBL] [Abstract][Full Text] [Related]
19. Pancreatic cancer: systemic combination therapies for a heterogeneous disease.
Melisi D; Calvetti L; Frizziero M; Tortora G
Curr Pharm Des; 2014; 20(42):6660-9. PubMed ID: 25341938
[TBL] [Abstract][Full Text] [Related]
20. Immuno- and gene-therapeutic strategies targeted against cancer (mainly focusing on pancreatic cancer).
Yoshimura K; Olino K; Edil BH; Schulick RD; Oka M
Surg Today; 2010 May; 40(5):404-10. PubMed ID: 20425541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
